Federico Grossi - 28 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol: APLS
Transactions as of: 28 Jun 2021
Net transactions value: +$33,840
Form type: 4
Filing time: 29 Jun 2021, 16:58:12 UTC
Previous filing: 15 Jun 2021
Next filing: 09 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$33,840	+9,000	+16%	$3.76^*	63,930	28 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-9,000	-38%	$0.000000	14,661	28 Jun 2021	Common Stock	9,000	$3.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on February 8, 2016 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.